Literature DB >> 10358923

Regulation of phospholipase C isozymes: activation of phospholipase C-gamma in the absence of tyrosine-phosphorylation.

F Sekiya1, Y S Bae, S G Rhee.   

Abstract

Activation of PLC-gamma isozymes in response to various agonists involves tyrosine phosphorylation of the effector enzymes. Recent evidence indicates that PLC-gamma isozymes are additionally activated by phosphatidic acid, phosphatidylinositol 3,4,5-trisphosphate and arachidonic acid in the absence of PLC-gamma tyrosine phosphorylation. These lipid-derived messengers are the immediate products of phospholipase D, phosphatidylinositol 3-kinase, and phospholipase A2, enzymes which are often stimulated along with PLC-gamma in response to an agonist. Furthermore, phosphatidylinositol 4,5-bisphosphate acts as a substrate for both PLC-gamma and phosphatidylinositol 3-kinase and as an activator for phospholipase D and phospholipase A2. These results reveal an elaborate mechanism of cross-talk and mutual regulation between four effector enzymes that participate in receptor signaling by acting on phospholipids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358923     DOI: 10.1016/s0009-3084(99)00013-4

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  13 in total

1.  Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors.

Authors:  Dusanka Deretic; Valerie Traverso; Nilda Parkins; Fannie Jackson; Elena B Rodriguez de Turco; Nancy Ransom
Journal:  Mol Biol Cell       Date:  2003-09-17       Impact factor: 4.138

Review 2.  VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy.

Authors:  Nader Rahimi
Journal:  Front Biosci       Date:  2006-01-01

3.  Sequential phosphorylation of SLP-76 at tyrosine 173 is required for activation of T and mast cells.

Authors:  Meirav Sela; Yaron Bogin; Dvora Beach; Thomas Oellerich; Johanna Lehne; Jennifer E Smith-Garvin; Mariko Okumura; Elina Starosvetsky; Rachelle Kosoff; Evgeny Libman; Gary Koretzky; Taku Kambayashi; Henning Urlaub; Jürgen Wienands; Jonathan Chernoff; Deborah Yablonski
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

4.  Regulation of Drosophila transient receptor potential-like (TrpL) channels by phospholipase C-dependent mechanisms.

Authors:  M Estacion; W G Sinkins; W P Schilling
Journal:  J Physiol       Date:  2001-01-01       Impact factor: 5.182

5.  Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.

Authors:  D Yablonski; T Kadlecek; A Weiss
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase in B cells.

Authors:  S Qin; E R Stadtman; P B Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 7.  Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

Authors:  Nader Rahimi
Journal:  Exp Eye Res       Date:  2006-05-19       Impact factor: 3.467

8.  Requirements for distinct steps of phospholipase Cgamma2 regulation, membrane-raft-dependent targeting and subsequent enzyme activation in B-cell signalling.

Authors:  Rosie Rodriguez; Miho Matsuda; Amy Storey; Matilda Katan
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Role of nonreceptor protein tyrosine kinases during phospholipase C-gamma 1-related uterine contractions in the rat.

Authors:  Mark Phillippe; Leigh M Sweet; Diana F Bradley; Daniel Engle
Journal:  Reprod Sci       Date:  2009-03       Impact factor: 3.060

10.  Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution.

Authors:  Evangelia A Papakonstanti; Christos Stournaras
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.